Patents Assigned to Q-LINEA AB
  • Patent number: 11261476
    Abstract: The present invention provides a method of recovering viable microbial cells from a complex sample, said method comprising: a) providing a sample having a volume of at least 1 ml; b) contacting said sample with a buffer solution and one or more proteases, wherein said buffer solution has a pH of at least pH 6 and less than pH 11, wherein said buffer solution and said one more proteases do not comprise a detergent or a chaotrope, and wherein the buffer solution/protease/sample mixture is non-hypotonic; c) filtering the mixture obtained in step (b) through a filter suitable for retaining microbial cells; and d) recovering the microbial cells retained by the filter in step (c), wherein the recovered microbial cells are viable, and a microbial recovery device for the same.
    Type: Grant
    Filed: October 19, 2017
    Date of Patent: March 1, 2022
    Assignee: Q-LINEA AB
    Inventors: Markus Klintstedt, Harer Osman, Mats Gullberg
  • Publication number: 20210246410
    Abstract: A portable apparatus and method for transport and incubation of a medical sample in a blood culture flask includes a sealable container having a thermally insulated compartment for receiving the blood culture flask and a heater for heating the medical sample to a temperature suitable for pre-culturing of the sample. An agitator is provided for agitating the sample in the blood culture flask.
    Type: Application
    Filed: March 26, 2021
    Publication date: August 12, 2021
    Applicant: Q-linea AB
    Inventors: Jonas Jarvius, Anders Lind, Henrik Soderstrom, Jan Grawe, Ian Fitzpatrick, Jurg Bartholdi
  • Publication number: 20210224978
    Abstract: A method of image-based analysis of multiple samples includes using a sample holder having multiple locations of interest and multiple focal structures that are each associated, one or more, with the multiple locations of interest, wherein the multiple samples are dispersed across the multiple locations of interest and obtaining image areas of the multiple locations of interest. Multiple digital image areas are thus obtained for use in an analysis of the multiple samples with each of the image areas including at least one of the locations of interest and at least one of the focal structures. An image processing algorithm is used to analyse each of the digital image areas and check if the focal structure indicates that the image area is in clear focus. An indication is provided and/or remedial action is taken if the image processing algorithm indicates that any digital image areas are out of focus.
    Type: Application
    Filed: June 15, 2017
    Publication date: July 22, 2021
    Applicant: Q-linea AB
    Inventors: Jonas Jarvius, Jan Grawe
  • Publication number: 20210154663
    Abstract: An apparatus for moving a sample holder 110 on a platform 652 from a loading position, where the sample holder 110 can be removed from the platform 652, to a locked position, where the sample holder 110 is securely held, wherein the sample holder 110 rests on wheels 690a within a recessed portion 651 on the platform 652, wherein the apparatus is configured such that movement from the loading position to the locked position causes a vertical clamping means 653 to lower down on top of the sample holder 110, and a horizontal clamping 657 means to be pressed to the outer periphery of the sample holder 110, and such that that movement from the locked position to the loading position causes the vertical clamping means 653 to raise above the sample holder 110, and the horizontal clamping means 657 to be moved away from the outer periphery of the sample holder 110.
    Type: Application
    Filed: April 23, 2019
    Publication date: May 27, 2021
    Applicant: Q-LINEA AB
    Inventors: Anders LIND, Henrik SÖDERSTRÖM, Henrik SVANBERG, Jan GRAWÉ, Johan SKABORN
  • Patent number: 10995311
    Abstract: A portable apparatus for transport and incubation of a medical sample in a blood culture flask includes a sealable container having a thermally insulated compartment for receiving the blood culture flask and a heater for heating the medical sample to a temperature suitable for pre-culturing of the sample. An agitator is provided for agitating the sample in the blood culture flask.
    Type: Grant
    Filed: April 21, 2016
    Date of Patent: May 4, 2021
    Assignee: Q-linea AB
    Inventors: Jonas Jarvius, Anders Lind, Henrik Soderstrom, Jan Grawe, Ian Fitzpatrick, Jurg Bartholdi
  • Publication number: 20210106987
    Abstract: An analysis instrument comprising a cartridge bay 20 for receiving a sample preparation cartridge 1, wherein the cartridge bay comprises: a first controllable heater 26 for heating a sample; a first temperature sensor for monitoring the temperature of the first controllable heater; and a second temperature sensor 28 for monitoring the temperature of the sample.
    Type: Application
    Filed: April 23, 2019
    Publication date: April 15, 2021
    Applicant: Q-LINEA AB
    Inventors: Anders LIND, Carl ROSENFELD
  • Publication number: 20210094035
    Abstract: A sample holder (10) comprises a sample chamber (33), a gas reservoir (32) and an upper layer (20) covering over the sample chamber (33) and gas reservoir (32), wherein a bottom surface of the upper layer (20) comprises a microstructure array (23) which overlies at least a portion of a top periphery of the sample chamber (33), and wherein the microstructure array (23) is in communication with a gas path which extends to the gas reservoir (32), to allow gas exchange between the sample chamber (33) and the gas reservoir (32).
    Type: Application
    Filed: January 22, 2019
    Publication date: April 1, 2021
    Applicant: Q-LINEA AB
    Inventors: Jonas MELIN, Simon UHRBERG, Jonas JARVIUS
  • Publication number: 20210032674
    Abstract: The present invention provides a method of preparing a suspension of intact microorganisms from a sample containing microorganisms and mammalian cells, comprising contacting the sample with a buffer solution with a pH of at least pH 6 and less than pH 9, a detergent and one or more proteases to allow lysis of the mammalian cells; filtering the mixture through a filter suitable for retaining microorganisms to remove the lysed mammalian cells; resuspending the microorganisms retained by the filter in a liquid to provide a suspension comprising the recovered intact microorganisms; and determining the concentration of microorganisms in the suspension by: i. heating and/or contacting an aliquot of the suspension with an alcohol; ii. optionally diluting one or more aliquots of the suspension to provide one or more diluted aliquots before, during and/or after step (i); iii. contacting at least a portion of an aliquot of step (i) or (ii) with a single fluorescent stain capable of binding to DNA; iv.
    Type: Application
    Filed: January 22, 2019
    Publication date: February 4, 2021
    Applicant: Q-LINEA AB
    Inventors: Jan GRAWÉ, Markus KLINTSTEDT
  • Patent number: 10902592
    Abstract: A method for analysis of a digital image in order to determine a value relating to an amount of a substance shown in the image includes using a threshold to identify all pixels of the digital image above or below a certain intensity value in order to produce a first binary image. Texture filtering is used to identify regions of high texture in the digital image to produce a second binary image in which all regions of high texture are pixels with a first state. The first and second binary images are overlayed to produce a combined binary image. A value relating to the amount of the substance is determined based on the area of the combined binary image with pixels having the first state.
    Type: Grant
    Filed: June 15, 2017
    Date of Patent: January 26, 2021
    Assignee: Q-Linea AB
    Inventors: Caroline Johansson, Amin Allalou, Ylva Molin, Magnus Sandow, Carolina Wahlby
  • Publication number: 20210017568
    Abstract: The present invention provides methods for determining the antimicrobial susceptibility of a microorganism in a clinical sample said method comprising removing a test aliquot from a clinical sample culture before the culture reaches 0.5 McFarland units, isolating the microbial cells and transferring the cells into a suitable culture medium for microbial growth, and performing an AST assay using the isolated microbes, wherein the concentration of microbial cells in the microbial cells used to set up the AST assay is measured before the degree of microbial growth in the different growth conditions of the AST assay is measured. Devices for determining the antimicrobial susceptibility of a microorganism in a clinical sample are also provided.
    Type: Application
    Filed: October 1, 2020
    Publication date: January 21, 2021
    Applicant: Q-linea AB
    Inventors: Jonas Jarvius, Jan Grawe, Ylva Molin, Markus Klintstedt, Mats Gullberg
  • Publication number: 20200363616
    Abstract: A method for performing microscopy-based imaging of samples comprises: loading a sample holder (100) onto a support (50) configured to receive the sample holder (100); moving the sample holder (100) in a first direction, from a starting position on a first strip of the sample holder (100), to move the sample holder (100) relative to an imaging line of a line camera (10), to capture an image of the first strip of the sample holder (100); monitoring a focal plane using an autofocus system (15) as the sample holder (100) is moved in the first direction; in response to a signal from the autofocus system (15), moving an objective lens (25) along the optical axis to adjust the focal plane; and moving the sample holder (100) in a second direction, to align the imaging line of the line camera (10) with a position on a second strip of the sample holder (100).
    Type: Application
    Filed: December 18, 2018
    Publication date: November 19, 2020
    Applicant: Q-LINEA AB
    Inventors: Jonas JARVIUS, Jan GRAWÉ
  • Patent number: 10829797
    Abstract: A method for determining the antimicrobial susceptibility of a microorganism in a clinical sample includes removing a test aliquot from a clinical sample culture before the culture reaches 0.5 McFarland units and isolating the microbial cells. The cells are transferred into a suitable culture medium for microbial growth and an AST assay is performed using the isolated microbes. The concentration of microbial cells in the microbial cells used to set up the AST assay is measured before measuring the degree of microbial growth in different conditions of the AST assay. Devices for determining the anti-microbial susceptibility of a microorganism in a clinical sample are also disclosed.
    Type: Grant
    Filed: June 16, 2016
    Date of Patent: November 10, 2020
    Assignee: Q-linea AB
    Inventors: Jonas Jarvius, Jan Grawe, Ylva Molin, Markus Klintstedt, Mats Gullberg
  • Patent number: 10831011
    Abstract: A sample holder 100 for use in a device for image-based analysis of multiple samples, the sample holder comprising: an optically flat surface 10; multiple locations of interest 16, 18 dispersed across the optically flat surface 10 that each, in use, correspond to locations of a sample of the multiple samples; and multiple focal structures 12 associated with the multiple locations of interest 16, 18; wherein the focal structures 12 each comprise at least one pyramid shaped indentation 30 in the optically flat surface 10.
    Type: Grant
    Filed: June 15, 2017
    Date of Patent: November 10, 2020
    Assignee: Q-Linea AB
    Inventors: Jonas Jarvius, Jan Grawe
  • Publication number: 20200338555
    Abstract: A sample holder (10) comprises: an upper layer (20); a lower layer (40); a middle layer (30) between the upper and lower layers; and a sample chamber (33) formed by a through-hole in the middle layer (30), covered at its upper extent by a portion of the bottom surface of the upper layer (20), and at its lower extent by a portion of the top surface of the lower layer (40), wherein at least part of the bottom surface of the upper layer (20) overlapping a portion of a top periphery of the sample chamber (33) comprises a hydrophobic surface, wherein the hydrophobic surface is sufficiently hydrophobic that a contact angle of a water droplet on the hydrophobic surface would exceed 110°.
    Type: Application
    Filed: January 22, 2019
    Publication date: October 29, 2020
    Applicant: Q-LINEA AB
    Inventors: Jonas MELIN, Simon UHRBERG, Jonas JARVIUS
  • Publication number: 20200318164
    Abstract: A method for detecting and characterizing a microorganism in a clinical sample includes introducing a clinical sample to a first culture vessel containing the culture medium; removing a test aliquot; separating DNA from the test aliquot; and performing nucleic acid tests on the DNA to identify the microorganism and to detect the presence or absence of one or more genetic antimicrobial resistance markers in the microorganism. If a microorganism is identified, an antimicrobial susceptibility test is performed wherein microbial growth in the antimicrobial susceptibility test is monitored by accessing growth or markers for growth and wherein the type and concentration of antimicrobial agents used in the antimicrobial susceptibility test is determined by the identity of the microorganism and the antimicrobial resistance markers detected. A device for performing the method is also provided.
    Type: Application
    Filed: April 9, 2020
    Publication date: October 8, 2020
    Applicant: Q-linea AB
    Inventors: Jonas Jarvius, Jan Grawe
  • Publication number: 20200299748
    Abstract: The present invention relates to a method of determining the concentration of intact microorganisms in a sample comprising optionally diluting an aliquot of the sample to provide a diluted aliquot at a dilution value; contacting at least a portion of an aliquot or of a diluted aliquot of the sample with first and second stains capable of binding to DNA, wherein the first stain is a fluorescent stain, is cell-permeable, and has a first emission wavelength, and the second stain is cell-impermeable, and is capable of acting as an acceptor molecule in a FRET pair with the first stain acting as a donor molecule; imaging the aliquot-stain mixture at the first emission wavelength and determining an image analysis value for the number of objects corresponding to intact microorganisms in the imaged mixture; and comparing the image analysis value for said aliquot to a pre-determined calibration curve, as well as an apparatus, a consumable and a kit therefor.
    Type: Application
    Filed: October 12, 2018
    Publication date: September 24, 2020
    Applicant: Q-LINEA AB
    Inventors: Jonas JARVIUS, Jan GRAWE, Markus KLINTSTEDT
  • Patent number: 10655188
    Abstract: A method for detecting and characterizing a microorganism in a clinical sample includes introducing a clinical sample to a first culture vessel containing the culture medium; removing a test aliquot; separating DNA from the test aliquot; and performing nucleic acid tests on the DNA to identify the microorganism and to detect the presence or absence of one or more genetic antimicrobial resistance markers in the microorganism. If a microorganism is identified, an antimicrobial susceptibility test is performed wherein microbial growth in the antimicrobial susceptibility test is monitored by accessing growth or markers for growth and wherein the type and concentration of antimicrobial agents used in the antimicrobial susceptibility test is determined by the identity of the microorganism and the antimicrobial resistance markers detected. A device for performing the method is also provided.
    Type: Grant
    Filed: June 12, 2015
    Date of Patent: May 19, 2020
    Assignee: Q-Linea AB
    Inventors: Jonas Jarvius, Jan Grawe
  • Publication number: 20200040376
    Abstract: Multiplexed methods of detecting an analyte in a sample using two or more padlock probes each specific to a different target sequence are described. The target sequence is either part of an analyte or indicative of the presence of an analyte in the sample. Each padlock probe includes an analyte-specific reporter sequence, and either a restriction cleavage site located 3? of the analyte-specific reporter sequence, and/or a first amplification primer binding site for an amplification reaction. Where the padlock probe includes a restriction cleavage site, cleavage at the restriction cleavage site occurs 3? of the analyte-specific reporter sequence. Where the padlock probe includes a first amplification primer binding site for the further amplification reaction, it does not contain a second amplification primer binding site 5? of the analyte-specific reporter sequence. Panels of probes and kits for the same are also described.
    Type: Application
    Filed: December 15, 2017
    Publication date: February 6, 2020
    Applicant: Q-linea AB
    Inventors: Camilla Russel, Jenny Goransson, Mats Gullberg
  • Patent number: D902428
    Type: Grant
    Filed: April 20, 2018
    Date of Patent: November 17, 2020
    Assignee: Q-linea AB
    Inventors: Markus Klintstedt, Peter Olsson, Anders Lind, Simon Uhrberg, Jerker Persson, Richard Kroon
  • Patent number: D950769
    Type: Grant
    Filed: October 11, 2019
    Date of Patent: May 3, 2022
    Assignee: Q-LINEA AB
    Inventors: Markus Klintstedt, Peter Olsson, Anders Lind, Simon Uhrberg, Richard Kroon, Jerker Persson, Charlotta Goransson, Emma Rennel Dickens